Shift in sphingolipid metabolism leads to an accumulation of ceramide in senescence

Mechanisms of Ageing and Development

Volumn 127, Issue 5, 2006, Pages 473-480

  Venable, Mark E ^a   Webb Froehlich, Lisa M ^a   Sloan, Eldon F ^a   Thomley, Jill E ^a  

^a APPALACHIAN STATE UNIVERSITY   (United States)

Author keywords

Aging; Caveolae; Ceramide; Endothelial; Fibroblast; Senescence; Sphingolipid

Indexed keywords

CERAMIDE; GLUCOSYLCERAMIDE; PALMITIC ACID; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; CELL AGING; CELL CULTURE; CELL LINE; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; LIPID METABOLISM; MITOSIS; PRIORITY JOURNAL; SENESCENCE; UMBILICAL VEIN;

AGING; ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; CELL AGING; CELLS, CULTURED; CERAMIDES; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GLUCOSYLCERAMIDES; HUMANS; LIPID METABOLISM; PALMITIC ACID; SPHINGOLIPIDS; SPHINGOMYELINS; THYMIDINE; TIME FACTORS;

EID: 33645880445     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2006.01.003     Document Type: Article

References (38)

1. Bieberich E. Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells. Glycocon. J. 21 (2004) 315-327
2. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
3. Campisi J. The thorny path linking cellular senescence to organismal aging. Mech. Aging Dev. 126 (2005) 1040-1045
4. Cuervo A.M., and Dice J.F. When lysosomes get old. Exp. Gerontol. (2000) 35
5. Cutler R.G., and Mattson M.P. Sphingomyelin and ceramide as regulators of development and lifespan. Mech. Aging Dev. 122 (2001) 895-908
6. Degroote S., Wolthoorn J., and van Meer G. The cell biology of glycosphingolipids. Semin. Cell Dev. Biol. 15 (2004) 375-387
7. DeJesus V., Rios I., Davis C., Chen Y., Calhoun D., Zakeri Z., and Hubbard K. Induction of apoptosis in human replicative senescent fibroblasts. Exp. Cell Res. 274 (2002) 92-99
8. Dimri G.P., Lee X., Basile G., Ascosta M., Scott G., Roskelley E., Medrano E.E., Linskens M., Rubeijll I., Pereira-Smith O., Peacocke M., and Campisi J. Abiomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1996) 9363-9367
9. Futerman A.H., and Hannun Y.A. The complex life of simple sphingolipids. EMBO Rep. 5 (2004) 777-782
10. Guillas I., Kirchman P.A., Chuard R., Pfefferli M., Jiang J.C., Jazwinski S.M., and Conzelmann A. C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. EMBO J. (2001) 2655-2665
11. Hannun Y.A., Luberto C., and Argraves K.M. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40 (2001) 4893-4903
12. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37 (1965) 614-636
13. Hofmann K., Tomiuk S., Wolff G., and Stoffel W. Cloning and characterization of the mammial brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5895-5900
14. Kirkland J.L. The biochemistry of mammalian senescence. Clin. Biochem. 25 (1992) 61-75
15. Kirkland J.L. The biology of senescence: potential for prevention of disease. Clin. Geriatr. Med. 18 (2002) 383-405
16. Kolesnick R., and Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene 22 (2003) 5897-5906
17. Lavie Y., Cao H.-t., Volner A., Lucci A., Han T.-Y., Geffen V., Giuliano A.E., and Cabot M.C. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J. Biol. Chem. 272 (1997) 1682-1687
18. Lightle S.A., Oakley J.I., and Nikolova-Karakashian M.N. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech. Aging Dev. 120 (2000) 111-125
19. Liu P., and Anderson R.G.W. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270 (1995) 27179-27185
20. Liu Y.-Y., Han T.-Y., Giuliano A.E., Ichikawa S., Hirabayashi Y., and Cabot M.C. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-α-induced apoptosis. Exp. Cell Res. 252 (1999) 464-470
21. Luberto C., and Hannun Y.A. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C. J. Biol. Chem. 273 (1998) 14550-14559
22. Mao C., Xu R., Szulc Z.M., Bielawska A., Galadari S.H., and Obeid L.M. Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J. Biol. Chem. 276 (2001) 26577-26588
23. Marchesini N., and Hannun Y.A. Acid and neutral sphingomyelinase: roles and mechanisms of regulation. Biochem. Cell Biol. 82 (2004) 27-44
24. Meacci E., Vasta V., Neri S., Farnararo M., and Bruni P. Activation of phospholipase D in human fibroblasts by ceramide and sphingosine: evaluation of their modulatory role in bradykinin stimulation of phospholipase D. Biochem. Biophys. Res. Commun. 225 (1996) 392-399
25. Merrill Jr. A.H. De Novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem. 277 (2002) 25843-25846
26. Mouton R.M., and Venable M.E. Ceramide induces senescence histochemical marker, β-galactosidase in human fibroblasts. Mech. Aging Dev. 113 (2000) 169-181
27. Ogretmen B., Kraveka J.M., Schady D., Usta J., Hannun Y.A., and Obeid L.M. Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line. J. Biol. Chem. 276 (2001) 32506-32514
28. Pagano R.E., Martin O.C., Kang H.C., and Haugland R.P. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: Accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J. Cell Biol. 113 (1991) 1267-1279
29. Park J.-S., Park W.-Y., Cho K.-A., Jhun B.-H., Kim D.-I., and Park S.-C. Down-regulation of amphiphysin-1 is responsible for reduced receptor-mediated endocytosis in the senescent cells. FASEB J. 15 (2001) 1625-1627
30. Park W.-Y., Park J.-S., Cho K.-A., Kim D.-I., Ko Y.-G., Seo J.-S., and Park S.-C. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J. Biol. Chem. 275 (2000) 20847-20852
31. Paul P., Kamisaka Y., Marks D.L., and Pagano R.E. Purification and characterization of UDP-glucose:ceramide glucosyltransferase from rat liver Golgi membranes. J. Biol. Chem. 271 (1996) 2287-2293
32. Tabas I. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?. Circulation 110 (2004) 3400-3401
33. Venable M.E., Blobe G.C., and Obeid L.M. Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J. Biol. Chem. 269 (1994) 26040-26044
34. Venable M.E., Lee J.Y., Smyth M.J., Bielawska A., and Obeid L.M. Role of ceramide in cellular senescence. J. Biol. Chem. 270 (1995) 30701-30708
35. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bc12 is involved. Cancer Res. 55 (1995) 2284-2292
36. Wheaton K., Sampsel K., Boisvert F.-M., Cavy A., Robbins S., and Riabowol K. Loss of functional caveolae during senescence of human fibroblasts. J. Cell. Physiol. 187 (2001) 226-235
37. Xu X., Bittman R., Duportail G., Heissler D., Vilcheze C., and London E. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). J. Biol. Chem. 276 (2001) 33540-33546
38. Xu Y.-H. Translational inefficiency of acid beta-glucosidase mrna in transgenic mammalian cells. Mol. Genet. Metab. 64 (1998) 87-98